I kliniske studier med ADVATE blev i alt 56 bivirkninger (ADRs) rapporteret hos 27 ud af 234 enkelt, behandlede patienter.
During clinical studies with ADVATE, a total of 56 adverse drug reactions (ADRs) were reported in 27 of 234 unique treated patients.